Arbutus Biopharma paid its 4 named executives $9.6M in total in FY2025 (Dec). CEO Lindsay Androski was paid $1.4M of that.
Pay$100 in the stock at the end of FY23 → $192
Pay of each named executive
Michael McElhaughFormer Interim President and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2022 (Dec) |
3 years
Tuan NguyenChief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
David C. HastingsFormer Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2023 (Dec) |
2 years
Lindsay AndroskiPresident and Chief Executive Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) |
2 years
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.